Currently, there are 1.44B common shares owned by the public and among those 1.43B shares have been available to trade.
The company’s stock has a 5-day price change of 4.51% and -20.33% over the past three months. FCX shares are trading 3.49% year to date (YTD), with the 12-month market performance down to -3.97% lower. It has a 12-month low price of $36.09 and touched a high of $55.07 over the same period. FCX has an average intraday trading volume of 11.12 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.45%, -6.76%, and -14.97% respectively.
Institutional ownership of Freeport-McMoRan Inc (NYSE: FCX) shares accounts for 84.53% of the company’s 1.44B shares outstanding.
It has a market capitalization of $56.63B and a beta (3y monthly) value of 1.86. The stock’s trailing 12-month PE ratio is 28.67, while the earnings-per-share (ttm) stands at $1.37. The company has a PEG of 1.17 and a Quick Ratio of 1.30 with the debt-to-equity ratio at 0.55. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.33% over the week and 2.56% over the month.
Earnings per share for the fiscal year are expected to decrease by -4.09%, and 37.55% over the next financial year. EPS should grow at an annualized rate of 24.61% over the next five years, compared to -6.56% over the past 5-year period.
Looking at the support for the FCX, a number of firms have released research notes about the stock. Bernstein stated their Mkt Perform rating for the stock in a research note on January 07, 2025, with the firm’s price target at $51-$46. Scotiabank coverage for the Freeport-McMoRan Inc (FCX) stock in a research note released on September 30, 2024 offered a Sector Perform rating with a price target of $52. UBS was of a view on September 04, 2024 that the stock is Buy, while Morgan Stanley gave the stock Overweight rating on June 21, 2024, issuing a price target of $49.50- $62. BofA Securities on their part issued Buy rating on April 09, 2024.
